TeleCareSpot Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.3/10
Best for: compounded semaglutide from $299 a month with delivery included
TeleCareSpot scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $299 a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
TeleCareSpot sells compounded semaglutide from $299 a month and compounded tirzepatide from $399 a month, each a monthly program with the medication, provider review and delivery included and no long-term commitment. It also lists oral tirzepatide with an optional DNA-guided dosing route, phentermine at $189 a month, and peptides. It serves every state but Alaska, Mississippi and New Jersey. The pharmacy is not named.
Is TeleCareSpot legit?
Yes. TeleCareSpot is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 6.3/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a TeleCareSpot promo or coupon code?
We know of no promo or coupon code for TeleCareSpot. Its listed price is $299 a month. Coupon sites advertising "TeleCareSpot discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how TeleCareSpot compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to TeleCareSpot
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
TeleCareSpot at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral tirzepatide
- Starting price
- $299/mo
- What's included
- Medication · Consult · Shipping
- Availability
- 47 states + DC
- FDA status
- No FDA warning letters found
How TeleCareSpot scores
Six columns, each one computed from something TeleCareSpot has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.0/10The listed figure is not a comparable monthly price for a named GLP-1 (it may be a membership fee, an insured copay, a per-vial rate or a starting-dose price), so Value is capped rather than scored against other sellers.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
6.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
9.5/10Serves 47 of 50 states and DC.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on TeleCareSpot
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: 47 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for TeleCareSpot
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with TeleCareSpot involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1TeleCareSpot shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask TeleCareSpot which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Before you commit, get the ongoing monthly price of the medication itself, not a first-month rate, a membership fee or a per-vial price.
- TeleCareSpot serves 47 of 50 states and DC, so check that yours is one of them.
Contacting TeleCareSpot
- TeleCareSpot offers email support
Cancelling TeleCareSpot
Taken from the terms TeleCareSpot publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Consult fee credited toward package if approved
- Early-termination fee
- None
Medications TeleCareSpot lists
TeleCareSpot lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides TeleCareSpot offers
TeleCareSpot sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
"Plans currently start at $299 per month"; includes provider evaluation, prescription management, care-team support, a monthly semaglutide supply if prescribed and home delivery where available.
"Monthly Tirzepatide Program $399 / month"; oral tirzepatide also listed, no public price.
Check the price yourself before you pay
Every figure here comes from TeleCareSpot's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- The monthly price includes the medication, clinician visits and shipping
- Serves 47 states and DC
- We found no FDA warning letters issued to TeleCareSpot
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What TeleCareSpot charges
TeleCareSpot lists $299/month. Before you pay, compare TeleCareSpot's cancellation terms with other sellers' cancellation and refund policies.
- Compounded semaglutide: $299/month
- Compounded tirzepatide: $399/month
MangoRx, at about $299/month, is the closest like-for-like alternative we review.
What TeleCareSpot dispenses
TeleCareSpot prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at TeleCareSpot at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
TeleCareSpot tells you the 47 states it serves. We found no FDA warning letters issued to TeleCareSpot. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If TeleCareSpot will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Of the peptides TeleCareSpot sells, BPC-157 is among the six in the October 2026 HHS compounding policy. It says HHS does not intend to take enforcement action against 503A pharmacies that compound them under ten conditions, and it approves none of them. TeleCareSpot also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether TeleCareSpot bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
Our read
TeleCareSpot charges $299/month. Too few sellers offer the same drug and form to say whether that is cheap or expensive, so judge it on what the package includes.
The Bottom Line
TeleCareSpot scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $299 a month.
Before you pay TeleCareSpot
Starting at $299 a month. Check today's price, then start the intake.
Where TeleCareSpot is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to TeleCareSpot sets more sellers in the same category beside TeleCareSpot on price, states and what the price includes.
Frequently Asked Questions
How to check TeleCareSpot yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
Every seller that ships to your state, side by side: Alabama, California, District of Columbia, Georgia, Maine, Michigan, New York, Wyoming and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this TeleCareSpot review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See TeleCareSpot's current pricing
Plans start at $299 a month. Whether you qualify is a clinician's decision, made after your intake.